Sunday, April 30, 2017 6 Filtered Mid-Day Market Movers Recap

Mid-Day Market Movers focus on above average volume, price action, breakout chart trends and news - posted throughout the day live at the top of and on our Hot Sheet, or follow our @InvestorsGuru Twitter feed or page. Below recaps last week's movers, all prices when posted, week high price Wk-H:, with a brief company description and recent news headlines. Submit any ticker symbol to our Detailed Quote Portal (top-left of all pages) for quotes, java charts, research and news, where you can also login with any major social account to post updates, comments, and share your own best ideas about any stock.

TSX Venture (quote V. and ticker symbol)
(TSXV:COR)(OTCBB:CAMZF) Camino Minerals Corp. (2014: $0.035 pre 10:1 rev.split) Apr.18 $0.63 $1.13 Wk-H: $1.70
- exploring high-grade copper in Peru, expands Los Chapitos: 10m 1.50% in 32m 0.64%, 16m 1.85% in 44m 0.86%; 38m 2.12% in 106m 1.30%
(TSXV:NXO)(OTCBB:NXOPF) NexOptic Technology Corp. (Feb.29 2016: $0.24) $2.08 Wk-H: $2.15
- imagery & light concentration apps. using its Blade Optics technology, initiates development of telephoto imaging system for mobile devices
(TSXV:PYR)(OTCBB:PYRNF) PyroGenesis Canada Inc. (Feb.29 2016: $0.20) $0.63 Wk-H: $0.79
- advanced plasma processes world leader, 2016 revenue -16%, margin +41%; EBITDA +33%, backlog $9.9M; 3D printing powders first order
(TSXV:ATW) AtmanCo Inc. $0.16 Wk-H: $0.205
- info tech: several web platforms, 298% annual revenue growth, $366K Q4 profit; psychometric test soon offered to US university students

(AMEX:BPMX) BioPharmX Corp. (Dec.2 2016: $0.37) $0.84 Wk-H: $0.90
- specialty pharma developing dermatology products, closes $5M $0.78/share; completes last subject visit Phase 2b trial BPX-01, May results

(NASDAQ:CYTR) CytRx Corp. $0.85 Wk-H: $0.99
- biopharm R&D specializing in oncology, focused on clinical development of aldoxorubicin in soft tissue sarcomas, offers $15M $0.50/share

Sign-up at (or for our Small Cap Stock Observer newsletter, and to set-up your own My Portfolio, My Watchlist & Alerts and News by Email preferences, or quote to comment at our Bulletin Boards. Free!

Please note that nothing in this report should be taken as a recommendation in any way, and that everything from is subject to the terms of our Privacy Policy and Disclaimer.

No comments:

Post a Comment